Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data

Tomas Kauer - Moderator

Sep 10, 2024 - 22:00

0

Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data

Tags:

Previous Article

EU's Vestager triumphs in crackdown on Apple's tax deal, Google's practices

Rubrik stock shines with raised guidance and strong cloud growth

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator www.tomaskauer.com

Related Posts

Teleo wants to help the robotics industry reach its ‘ChatGPT moment’

Teleo wants to help the robotics industry reach its ‘Ch...

Tomas Kauer - Mode... Nov 22, 2024 0

Titanic shipbuilder Harland & Wolff's CFO resigns

Titanic shipbuilder Harland & Wolff's CFO resigns

Tomas Kauer - Mode... Sep 12, 2024 0

Flooding in Thailand maroons thousands in northern province

Flooding in Thailand maroons thousands in northern prov...

Tomas Kauer - Mode... Sep 12, 2024 0